| Global Pharmaceutical Drugs Industry: Competitive Landscape 2023 (PHM263B) |
| Specialty Medications |
|
Sun Pharma has developed a portfolio of patent-protected specialty medicines for global markets. Over the years, the company has strengthened this growing business through strategic investments and a heightened focus. The company's key target segments include dermatology, ophthalmology, and oncology. The company is committed to improving patient outcomes by addressing unmet medical needs or enhancing convenience through innovative and differentiated dosage forms.
|
| Generic Medications |
|
The company offers high-quality generic and branded medicines at affordable prices to patients and healthcare professionals across more than 100 countries. Its products are distinguished by technology-driven innovation and span a comprehensive range of dosage forms, including tablets, capsules, injectables, inhalers, ointments, creams, and liquids. With a portfolio of over 2,000 molecules, the company serves diverse therapeutic areas such as psychiatry, anti-infectives, neurology, ophthalmology, nephrology, urology, dermatology, gynecology, cardiology, orthopedics, diabetology, gastroenterology, respiratory, oncology, dental care, and nutrition. The company is recognized as a leader in several markets in these therapeutic segments.
|
| Over-the-Counter Medications |
|
The company offers various over the counter (OTC) and consumer healthcare products. Among its flagship OTC brands marketed globally are Faringosept (for sore throat), Revital (vitamins), and Volini (topical analgesics). Additionally, the portfolio includes category-defining brands such as Coldact and Flustat (cold & flu), Brustan, Painamol, and Paduden (analgesics), Aspenter, Aspacardin, Nudrate, and Fortifikat (lifestyle OTCs), Gestid (digestive health), and Chericof (cough relief).
|
|
